An #obesity therapy developed by #HengruiPharma and #KaileraTherapeutics is being prepared for its first regulatory submission – in #China – after achieving impressive #weightloss in a phase 3 trial.

pharmaphorum.com/news/hengrui...

Obesity Weekly News – May 27th 2025 Obesity Advancements: Ascletis’ Combo Trial, Mazdutide’s NEJM Breakthrough, Novo CEO Exit & more In this week’s Obesity Updates, we’re spotlighting […] The post Obesity Weekly News – May 27th 2025 appeared first on LucidQuest Ventures.

FYI: LucidQuest Views >>> Obesity Weekly News – May 27th 2025 #News #GLP1 #HengruiPharma #mazdutide #NovoNordisk Comment below!

Obesity Weekly News – May 27th 2025 Obesity Advancements: Ascletis’ Combo Trial, Mazdutide’s NEJM Breakthrough, Novo CEO Exit & more In this week’s Obesity Updates, we’re spotlighting […] The post Obesity Weekly News – May 27th 2025 appeared first on LucidQuest Ventures.

ICYMI: LucidQuest Views >>> Obesity Weekly News – May 27th 2025 #News #GLP1 #HengruiPharma #mazdutide #NovoNordisk Comment below!

Obesity Weekly News – May 27th 2025 Obesity Advancements: Ascletis’ Combo Trial, Mazdutide’s NEJM Breakthrough, Novo CEO Exit & more In this week’s Obesity Updates, we’re spotlighting […] The post Obesity Weekly News – May 27th 2025 appeared first on LucidQuest Ventures.

LucidQuest Views >>> Obesity Weekly News – May 27th 2025 #News #GLP1 #HengruiPharma #mazdutide #NovoNordisk Comment below!

Click Subscribe #HengruiPharma #HongKongStocks #StockMarket #Pharmaceuticals #Investing

The Top Sponsors in Rare Diseases Clinical Trials Initiations ✔ Brazil SFE® - André Luiz Bernardes ♕Data Science ✰BI, Big Data & Analytics, ✰Market Intelligence, ♕Sales Force Effectiveness...

brazilsfe.blogspot.com/2024/11/blog...
The Top Sponsors in Rare Diseases Clinical Trials Initiations
✔ Brazil SFE®

#Roche #AstraZeneca #Merck #BristolMyersSquibb #Pfizer #HengruiPharma #SinoBiopharmaceutical #Novartis #AbbVie #Incyte #JohnsonandJohnson #Sanofi #EnsaiosClínicos